Navigation Links
Ontario Institute for Cancer Research Announces Spin Off Companies Developing Promising Anticancer Technologies
Date:5/19/2011

TORONTO, May 19, 2011 /PRNewswire/ -- The Ontario Institute for Cancer Research (OICR) today announced investments in three new Ontario companies aimed at bringing promising anticancer technologies to market.

"The establishment of these innovative companies will help bring commercial and operational leadership that will accelerate the development and market acceptance of their promising assets," said Frank Stonebanks, Vice-President, Commercialization and Chief Commercial Officer of OICR. "With early translational research, seed capital and professional management, OICR is committed to supporting the most promising new approaches to fighting cancer."

"The anticancer technologies developed by these companies offer hope for improved health outcomes for people in Ontario and around the world who are fighting cancer," said Glen Murray, Ontario Minister of Research and Innovation. "These three companies represent the best in Ontario innovation and are creating high-quality jobs with world-class researchers in this province."

Following extensive due diligence review by OICR, investments have been made in the following companies as their technologies have the potential to be best in class and advance OICR's commitment to the prevention, early detection, diagnosis and treatment of cancer. They include the following:

  • TORCell Therapeutics Inc., Developing a Novel Cellular Immunotherapy for Cancer

TORCell was created by OICR and the University Health Network (UHN) to undertake clinical development of a proprietary, immunotherapy for the treatment of acute myeloid leukemia (AML), a form of cancer with a very poor prognosis and limited treatment options. The technology involves using a sub-population of the patient's own cancer-killing T cells whose potential in treating AML has been pioneered by Dr. Li Zhang, Senior Scientist in the Division of Cellular and Molecular Biology at the UHN's
'/>"/>

SOURCE Ontario Institute for Cancer Research
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Ontario Institute for Cancer Research Announces Investment in Microfluidics Technology for the Discovery of Anti-Cancer Drugs
2. Ontario Institute for Cancer Research Announces Enhancements to its Intellectual Property Development and Commercialization Program
3. Ontario Institute for Cancer Research Validates NEBNext(TM) DNA Sample Preparation Reagents from New England Biolabs for use in Next Generation Sequencing
4. Ludwig Institute for Cancer Research and Polaris Group Form Collaboration to Expand Development of Polaris Novel Cancer Drug, ADI-PEG 20
5. Northwest Biotherapeutics and the Fraunhofer Institute for Cell Therapy and Immunology are Partnering for Clinical Trials and Compassionate Use Cases in Europe
6. Larta Institute Receives Award for National Institutes of Health Commercialization Assistance Program at 2011 Acquisition, Grants, and Small Business Symposium
7. Van Andel Institute Earns Highest "Green Building" Award
8. LifeNet Health Breaks Ground on New Institute of Regenerative Medicine
9. The Wound Institute® to Feature Educational Forum on Dynamic Reciprocity During the Symposium on Advanced Wound Care and the Wound Healing Society Annual Meeting
10. MabVax Therapeutics Receives $1.8 Million in a Phase 2 Small Business Innovation Research Program Award From the National Cancer Institute
11. IBM and The Institute of Bioengineering and Nanotechnology Find Breakthrough for MRSA Treatment
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2015)... 26. mája 2015 Kevin Xu ... rodiny prezidentom Barackovi Obamovi a Billovi Clintonovi za ... stratou Dr. Rongxiang Xu , otca Kevina. ... Dr. Xu bol pionier, inovátor, humanitárny ... odhodlanie v oblasti vedy a príkladné vedenie svojej ...
(Date:5/26/2015)... -- Oramed Pharmaceuticals Inc. (NASDAQ: ORMP ... on the development of oral drug delivery systems, announced ... the company,s Phase IIb trial of ORMD-0801, its oral ... (FDA). The submission was made under the company,s existing ... IIb study of ORMD-0801 for type 2 diabetics is ...
(Date:5/26/2015)... NEW YORK , May 26, 2015 ... NVGN ), announced today that it will present at the ... New York City at the Grand Hyatt ... Kelly , Novogen Chairman and CEO, is scheduled to begin at ... To access the webcast, go to http://wsw.com/webcast/marcum3/nvgn . ...
(Date:5/25/2015)... a science-driven healthcare company seeking to solve some of ... that Dame Marjorie Scardino , Chairman of the ... appointed to PureTech,s Board of Directors in the role ... Joi Ito , MIT Media Lab,s Director, has ... PureTech,s outgoing Chairman and co-founder, former Executive Vice President ...
Breaking Biology Technology:Dr. Rongxiang Xu, O legende 2Oramed Submits Protocol to U.S. FDA for Its Phase IIb Oral Insulin Study 2Oramed Submits Protocol to U.S. FDA for Its Phase IIb Oral Insulin Study 3Novogen to Present at the 2015 Marcum Microcap Conference 2Novogen to Present at the 2015 Marcum Microcap Conference 3Novogen to Present at the 2015 Marcum Microcap Conference 4PureTech Adds Dame Marjorie Scardino to Board of Directors, Names Joi Ito as Chairman of the Board and Expands Management Team 2PureTech Adds Dame Marjorie Scardino to Board of Directors, Names Joi Ito as Chairman of the Board and Expands Management Team 3
... , , , KALAMAZOO, Mich., Sept. ... it will participate in the following investor conferences: , , ... Global Healthcare Unplugged Conference , New York, New York , , ... Global Life Sciences Conference , New York, New York , , ...
... ViroPharma Incorporated (Nasdaq: VPHM ) today announced that ... during the month of September. , , ... present at the Rodman & Renshaw 11th Annual Global Healthcare Conference ... conference is being held at the New York Palace Hotel. , ...
... AURORA, Ontario, Sept. 3 Helix BioPharma Corp. (TSX, FSE: ... and chief operating officer, will present at the Rodman and ... Wednesday, Sept. 9, at the New York Palace Hotel in ... the Company,s leading product development programs L-DOS47 and Topical Interferon ...
Cached Biology Technology:Stryker to Present at Investor Conferences 2ViroPharma to Present at Several Upcoming Healthcare Conferences 2Helix Biopharma to Present at the Rodman & Renshaw 11th Annual Healthcare Conference 2Helix Biopharma to Present at the Rodman & Renshaw 11th Annual Healthcare Conference 3
(Date:5/25/2015)... SYDNEY , May 25, 2015  Australia,s market ... inception stage, although 2014 saw the advent of several ... on 24 April 2015 is expected to ignite interest ... devices in Australia . This in ... the industry and drive new partnerships amongst vendors and ...
(Date:5/22/2015)... , May 22, 2015 ... Market by Solution (2D, 3D, Thermal, Emotion, Forensic), by Software ... User (Government and Utilities, Consumer and Home) - Global ... to grow from $2.77 Billion in 2015 to $6.19 ... Browse 79 market data Tables and   ...
(Date:5/21/2015)... BOSTON , May 21, 2015 ... scientific potential of music for health, today announced a ... (BerkleeICE) . The partnership will center on collaboration on ...  As a first step in the collaboration, The Sync ... course on "Music as Medicine" in the 2015-2016 academic ...
Breaking Biology News(10 mins):Australian wearables market to grow at CAGR of 78%; revenue of A$1 billion by 2018, says Frost & Sullivan 2Australian wearables market to grow at CAGR of 78%; revenue of A$1 billion by 2018, says Frost & Sullivan 3Australian wearables market to grow at CAGR of 78%; revenue of A$1 billion by 2018, says Frost & Sullivan 4Facial Recognition Market Worth $6.19 Billion by 2020 2Facial Recognition Market Worth $6.19 Billion by 2020 3The Sync Project Announces Partnership with Berklee College of Music's Institute for Creative Entrepreneurship 2The Sync Project Announces Partnership with Berklee College of Music's Institute for Creative Entrepreneurship 3
... the womb. Inserting a tiny laser into the mother,s uterus ... twins. Advancing the science that may allow doctors to deliver ... genetic diseases before birth. These are examples of the ... field in maternal-fetal medicine," said pediatric surgeon N. Scott Adzick, ...
... Irvine, Calif., Feb. 16, 2010 Butterfly experts have ... key role in explaining wing color diversity. Now, for the ... theory true at least in nine Heliconius ... to see ultraviolet colors also have UV-yellow pigment on their ...
... of induced pluripotent stem cells is that the all-purpose cells ... stem cells, but without the controversy. However, a new ... of the National Academy of Sciences comparing the ability ... cells of the brain has found that induced cells ...
Cached Biology News:Fetal surgery continues to advance 2Fetal surgery continues to advance 3Fetal surgery continues to advance 4Butterfly vision, wing colors linked, UCI study finds 2Induced neural stem cells: Not quite ready for prime time 2
... easy-to-use kits for arraying proteins of ... common lab equipment. DiscoverLight Protein Array ... your protein, cell lysate or antibody ... kits include specially designed nitrocellulose membranes ...
... formulated specifically for Alkaline Phosphatase conjugates. ... activity for both the enzyme and the ... This product has been chemically engineered ... a longer shelf life, resistance to various ...
Request Info...
NovaScreen offers cell biology, cell culture and molecular biology services for companies who lack a cell culture facility....
Biology Products: